John Overdeck’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.73M Buy
94,600
+57,400
+154% +$3.74M 0.01% 1537
2026
Q1
$1.77M Buy
+37,200
New +$1.67M ﹤0.01% 2850
2025
Q4
Sell
-73,755
Closed -$2.08M 4438
2025
Q3
$2.08M Sell
73,755
-42,200
-36% -$1.28M ﹤0.01% 2100
2025
Q2
$4.27M Sell
115,955
-24,721
-18% -$854K 0.01% 1324
2025
Q1
$5.52M Sell
140,676
-206,856
-60% -$9.32M 0.01% 1074
2024
Q4
$16.1M Sell
347,532
-72,056
-17% -$3.26M 0.04% 555
2024
Q3
$19M Sell
419,588
-159,639
-28% -$7.6M 0.04% 506
2024
Q2
$28.5M Buy
579,227
+315,095
+119% +$12.8M 0.07% 349
2024
Q1
$9.06M Buy
264,132
+58,531
+28% +$2.11M 0.02% 689
2023
Q4
$7.58M Sell
205,601
-104,820
-34% -$2.42M 0.02% 793
2023
Q3
$6.29M Buy
310,421
+235,659
+315% +$5.18M 0.02% 784
2023
Q2
$1.53M Sell
74,762
-416,670
-85% -$6.24M ﹤0.01% 1676
2023
Q1
$7.41M Buy
491,432
+440,932
+873% +$9.74M 0.02% 724
2022
Q4
$1.2M Sell
50,500
-34,501
-41% -$1M ﹤0.01% 1610
2022
Q3
$3M Buy
+85,001
New +$3.61M 0.01% 972
2022
Q2
Sell
-192,086
Closed -$9.48M 2944
2022
Q1
$9.48M Buy
192,086
+149,143
+347% +$8.27M 0.03% 627
2021
Q4
$3.32M Sell
42,943
-9,887
-19% -$1.01M 0.01% 1496
2021
Q3
$5.65M Sell
52,830
-9,760
-16% -$1.12M 0.01% 1144
2021
Q2
$8.34M Sell
62,590
-215,635
-78% -$25.1M 0.02% 909
2021
Q1
$34.5M Buy
278,225
+233,582
+523% +$35.5M 0.09% 259
2020
Q4
$6.31M Buy
44,643
+9,766
+28% +$1.08M 0.02% 796
2020
Q3
$2.65M Buy
+34,877
New +$2.17M 0.01% 1139
2020
Q1
Sell
-61,537
Closed -$1.29M 3844
2019
Q4
$1.29M Buy
+61,537
New +$1.44M ﹤0.01% 1953
2019
Q3
Sell
-52,359
Closed -$1.52M 3809
2019
Q2
$1.52M Buy
+52,359
New +$1.39M 0.01% 1622

Other funds holding TWST

John Overdeck's TWST Position: Q2 2026 in Review

John Overdeck increased its Twist Bioscience (TWST) stake by 154% in Q2 2026, buying an estimated $3.74M and bringing the position to 94,600 shares worth $9.73M. The position accounts for 0.01% of the portfolio, ranked #1537.

John Overdeck first reported a position in TWST in Q2 2019 and has held it in 24 quarters since. The position peaked at $34.5M in Q1 2021. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • John Overdeck held 94,600 shares of Twist Bioscience worth $9.73M as of Q2 2026.
  • John Overdeck bought 57,400 Twist Bioscience shares in Q2 2026, an estimated $3.74M.
  • Twist Bioscience made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1537 holding.
  • John Overdeck first reported a position in Twist Bioscience in Q2 2019 and has held it in 24 quarters since.
  • John Overdeck's Twist Bioscience position peaked at $34.5M in Q1 2021.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.